Many have speculated it's Ozempic, a brand name GLP-1 agonist that's been approved by the U.S
Research on Antioxidant Role in Schizophrenia and Psychosis Points to Possible Therapeutic Value of Compound Found in Broccoli Researchers at Johns Hopkins University co-led by Akira Sawa, M.D., Ph.D., a BBRF Scientific Council member, and including seven other current and past BBRF grant recipients, have published a trio of papers which report new developments pertaining to the diagnosis and treatment of first-episode psychosis and schizophrenia
Watson, J
Companies that work the system For people who cannot afford a compounding pharmacy product, or cannot get a valid prescription for semaglutide or tirzepatide, opportunistic companies are stepping in to fill the void
Safety and Best Practices for MIC B12 When you're thinking about getting MIC B12 injections, it's really important to know about the safety side of things
Cannot redeclare control with same name "grid_4_rating_spacing"